Michael Feeley

406 total citations
23 papers, 331 citations indexed

About

Michael Feeley is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Michael Feeley has authored 23 papers receiving a total of 331 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Michael Feeley's work include Tracheal and airway disorders (5 papers), Heat shock proteins research (5 papers) and Ultrasound and Hyperthermia Applications (4 papers). Michael Feeley is often cited by papers focused on Tracheal and airway disorders (5 papers), Heat shock proteins research (5 papers) and Ultrasound and Hyperthermia Applications (4 papers). Michael Feeley collaborates with scholars based in Canada, United States and Austria. Michael Feeley's co-authors include G. P. Raaphorst, Cyril Danjoux, Michael K. Murphy, Kevin Motz, Dacheng Ding, Edouard I. Azzam, Alexander T. Hillel, William C. Dewey, L Gerig and J. M. Kanabus‐Kaminska and has published in prestigious journals such as Environmental Health Perspectives, Free Radical Biology and Medicine and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Michael Feeley

23 papers receiving 322 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Feeley Canada 12 116 102 73 54 47 23 331
Murali Mohan Sagar Balla India 9 98 0.8× 35 0.3× 48 0.7× 57 1.1× 69 1.5× 18 390
Karen M. Price United Kingdom 13 249 2.1× 56 0.5× 27 0.4× 48 0.9× 54 1.1× 28 642
Gissela Borrego‐Soto Mexico 6 126 1.1× 44 0.4× 39 0.5× 51 0.9× 48 1.0× 14 316
M Bernarding United States 6 187 1.6× 85 0.8× 23 0.3× 153 2.8× 39 0.8× 6 358
Hyun Sook Jung South Korea 13 132 1.1× 47 0.5× 53 0.7× 24 0.4× 15 0.3× 26 524
Aleksandra Krzywon Poland 8 98 0.8× 136 1.3× 26 0.4× 87 1.6× 62 1.3× 23 338
Joong Won Lee South Korea 10 101 0.9× 33 0.3× 26 0.4× 37 0.7× 20 0.4× 24 291
Gianfranco Baronzio Italy 10 112 1.0× 50 0.5× 149 2.0× 40 0.7× 62 1.3× 23 354
Feinendegen Le Germany 11 69 0.6× 70 0.7× 16 0.2× 145 2.7× 40 0.9× 50 316
Mario López Spain 5 58 0.5× 90 0.9× 36 0.5× 149 2.8× 68 1.4× 7 301

Countries citing papers authored by Michael Feeley

Since Specialization
Citations

This map shows the geographic impact of Michael Feeley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Feeley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Feeley more than expected).

Fields of papers citing papers by Michael Feeley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Feeley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Feeley. The network helps show where Michael Feeley may publish in the future.

Co-authorship network of co-authors of Michael Feeley

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Feeley. A scholar is included among the top collaborators of Michael Feeley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Feeley. Michael Feeley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tsai, Hsiu‐Wen, Ioan Lina, Kevin Motz, et al.. (2021). Glutamine Inhibition Reduces Iatrogenic Laryngotracheal Stenosis. The Laryngoscope. 131(7). E2125–E2130. 7 indexed citations
2.
Tsai, Hsiu‐Wen, Kevin Motz, Dacheng Ding, et al.. (2020). Inhibition of glutaminase to reverse fibrosis in iatrogenic laryngotracheal stenosis. The Laryngoscope. 130(12). E773–E781. 16 indexed citations
3.
Murphy, Michael K., Kevin Motz, Dacheng Ding, et al.. (2017). Targeting metabolic abnormalities to reverse fibrosis in iatrogenic laryngotracheal stenosis. The Laryngoscope. 128(2). E59–E67. 13 indexed citations
4.
Feeley, Michael. (1995). Workshop on perinatal exposure to dioxin-like compounds. III. Endocrine effects.. Environmental Health Perspectives. 103(suppl 2). 147–150. 7 indexed citations
5.
Feeley, Michael. (1995). Biomarkers for Great Lakes priority contaminants: halogenated aromatic hydrocarbons.. Environmental Health Perspectives. 103(suppl 9). 7–16. 20 indexed citations
6.
Raaphorst, G. P., et al.. (1993). A comparison of the effect of hyperthermia on DNA polymerase in hamster and human glioma cells. International Journal of Hyperthermia. 9(2). 303–312. 11 indexed citations
7.
Feeley, Michael, et al.. (1992). A comparison of heat sensitivity, radiosensitivity and PLDR in four human melanoma cell lines. Melanoma Research. 2(1). 63–70. 11 indexed citations
8.
Raaphorst, G. P., et al.. (1991). Enhancement of sensitivity to hyperthermia by Lonidamine in human cancer cells. International Journal of Hyperthermia. 7(5). 763–772. 7 indexed citations
9.
Raaphorst, G. P., et al.. (1991). Hyperthermia enhancement of radiation response and inhibition of recovery from radiation damage in human glioma cells. International Journal of Hyperthermia. 7(4). 629–641. 15 indexed citations
10.
Raaphorst, G. P., et al.. (1991). The effect of lonidamine (LND) on radiation and thermal responses of human and rodent cell lines. International Journal of Radiation Oncology*Biology*Physics. 20(3). 509–515. 9 indexed citations
12.
Raaphorst, G. P., et al.. (1991). The in vitro effects of lonidamine combined with cisplatin in human small cell lung cancer cell lines. Lung Cancer. 7(6). 396–396. 2 indexed citations
13.
Raaphorst, G. P. & Michael Feeley. (1990). Comparison of recovery from potentially lethal damage after exposure to hyperthermia and radiation.. PubMed. 121(1). 107–10. 3 indexed citations
15.
Raaphorst, G. P., Michael Feeley, Dennis Heller, et al.. (1990). Lonidamine can enhance the cytotoxic effect of cisplatin in human tumour cells and rodent cells.. PubMed. 10(4). 923–7. 13 indexed citations
16.
Székely, J., et al.. (1989). Morphological effects of lonidamine on two human-tumor cell culture lines.. PubMed. 3(2). 681–91; discussion 691. 9 indexed citations
17.
Raaphorst, G. P., et al.. (1989). A comparison of heat and radiation sensitivity of three human glioma cell lines. International Journal of Radiation Oncology*Biology*Physics. 17(3). 615–622. 29 indexed citations
18.
Kanabus‐Kaminska, J. M., Michael Feeley, & H.C. Birnboim. (1988). Simultaneous protective and damaging effects of cysteamine on intracellular DNA of leukocytes. Free Radical Biology and Medicine. 4(3). 141–145. 21 indexed citations
19.
Raaphorst, G. P., Edouard I. Azzam, M. D. Sargent, & Michael Feeley. (1988). Reduced pH Increases Recovery from Radiation Damage Potentially Leading to Cell Death and to in Vitro Transformation. International Journal of Radiation Biology. 54(6). 1031–1040. 7 indexed citations
20.
Raaphorst, G. P., Edouard I. Azzam, & Michael Feeley. (1988). Potentially Lethal Radiation Damage Repair and Its Inhibition by Hyperthermia in Normal Hamster Cells, Mouse Cells, and Transformed Mouse Cells. Radiation Research. 113(1). 171–171. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026